Why Ebola vaccine on trial in the DRC is raising hopes


Vaccine development for challenging diseases like Ebola and Marburg viruses remains a very difficult task. The pace at which the rVSV-ZEBOV vaccine has been developed and implemented, in addition to the effectiveness of the ring vaccination strategy, has paved a way for dealing with future outbreaks.

Content Information

Content Author: 
Shirin Ashraf, Arthur Wickenhagen
Content Source: 
Conversation
Content Type: 
News